Sun Pharmaceutical Industries Limited - Company Profile

It is a pharma public limited company based in Vadodara, Gujarat, India, established in 1993.

1993 Vadodara, Gujarat, India Active

Last Updated: December 18, 2025

About Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Limited, a active public limited company, was established on 01 March 1993 in Vadodara, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24230GJ1993PLC019050. Registered under ROC Roc Ahmedabad. it is listed on BSE: 524715 and NSE: SUNPHARMA. It has an authorized capital of ₹600.00 Cr and a paid-up capital of ₹239.93 Cr.

It upholds a compliant status. In 2025, it reported revenue of ₹23,372.76 Cr and a net worth of ₹24,339.85 Cr. Employing 16,436 professional, Its leadership includes Dilip Shantilal Shanghvi (Whole-Time Director), Pawan Kumar Goenka (Director), Anoop Anjanikumar Deshpande (Nodal Officer). Past directors included Sailesh Trambaklal Desai, Sudhir Vrundavandas Valia, Dilip Shantilal Shanghvi. It holds ₹16.06 Cr open charges and ₹1,785.22 Cr settled loans. Its latest AGM occurred on 31 July 2025, with the balance sheet filed on 31 March 2025. It is based at Sparc, Tandalja,, Vadodara, Gujarat, 390012.

Company Details

CIN/LLPIN
L24230GJ1993PLC019050
Registration Number
019050
Incorporation Date
01 March 1993
Authorized Capital
₹600.00 Cr
Paid-Up Capital
₹239.93 Cr
ROC Code
Roc Ahmedabad
Listing Status
Listed (BSE: 524715, NSE: SUNPHARMA)
Company Status
Active

Key Metrics

Authorised Capital ₹ 600.00 Cr as on 18-12-2025
Paid Up Capital ₹ 239.93 Cr as on 18-12-2025
Company Age 33 Year, 2 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 16.06 Cr as on 18-12-2025
Satisfied Charges ₹ 1,785.22 Cr as on 18-12-2025
Revenue Growth **** 12.69% (FY 2025)
Profit Growth **** 49.84% (FY 2025)
Ebitda **** 28.18% (FY 2025)
Net Worth 2.72% (FY 2025)
Total Assets **** 4.29% (FY 2025)

Comprehensive Company Insights

Explore comprehensive insights into Sun Pharmaceutical Industries Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Sun Pharmaceutical Industries Limited?

Current Directors

Name	Designation	Appointment Date	Status
Dilip Shantilal Shanghvi	Whole-Time Director	01 Apr 2008	Current
Pawan Kumar Goenka	Director	21 May 2021	Current
Anoop Anjanikumar Deshpande	Nodal Officer	05 Feb 2022	Current
Meetal Sharad Sampat	Deputy Nodal Officer	11 Sep 2019	Current
Kirti Wardhaman Ganorkar	Managing Director	01 Sep 2025	Current
Rama Bijapurkar	Director	21 May 2021	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Whole-Time Director	31 Mar 2024	Past
Pramod Abcsdd	Whole-Time Director	29 May 2019	Past
Pramod Abcsdd	Managing Director	21 May 2024	Past
Pramod Abcsdd	Deputy Nodal Officer	07 Jun 2022	Past
Pramod Abcsdd	Additional Director	31 Aug 2021	Past
Pramod Abcsdd	Company Secretary	-	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sun Pharmaceutical Industries.

Sun Pharmaceutical Industries Limited, for the financial year ended 2025, experienced significant growth in revenue, with a 12.69% increase. The company also saw a substantial improvement in profitability, with a 49.84% increase in profit. The company's net worth moved up by a moderate rise of 2.72%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

12.69%

*******

Revenue from Operations

*******

13.46%

*******

Total Assets

*******

4.29%

*******

Profit or Loss

*******

49.84%

*******

Net Worth

*******

2.72%

*******

EBITDA

*******

28.18%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sun Pharmaceutical Industries?

In 2024, Sun Pharmaceutical Industries had a promoter holding of 54.47% and a public holding of 45.53%. The company had 14 Subsidiaries and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹160,600,000.00

Satisfied Charges

₹17,852,171,000.00

Charges Breakdown by Lending Institutions

Industrial Development Bank Of India : 12.45 Cr
Risk Capital And Technology Finance Corporation Ltd : 1.50 Cr
Gujarat Industrial Investment Corporation Ltd. : 1.36 Cr
Nvfc Finance Private Ltd : 0.75 Cr

Latest Charge Details

Date	Lender	Amount	Status
26 May 1999	Nvfc Finance Private Ltd	₹7.50 M	Open
29 Apr 1999	Risk Capital And Technology Finance Corporation Ltd	₹1.50 Cr	Open
17 Nov 1998	Industrial Development Bank Of India	₹3.25 Cr	Open
13 Sep 1996	Industrial Development Bank Of India	₹9.20 Cr	Open
11 Oct 1993	Gujarat Industrial Investment Corporation Ltd.	₹1.36 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Sun Pharmaceutical Industries?

Sun Pharmaceutical Industries has a workforce of 16436 employees as of Oct 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Sun Pharmaceutical Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sun Pharmaceutical Industries's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sun Pharmaceutical Industries

Recent Activity within the Organization

Director Appointment

Progress on Kirti Wardhaman Ganorkar was appointed as a Managing Director was appointed as a Managing Director on 01 Sep 2025 & has been associated with this company since 8 months 18 days . was documented.
01 Sep 2025
Annual General Meeting

Sun Pharmaceutical Industries Limited last Annual general meeting of members was held on 31 Jul 2025 as per latest MCA records. was recorded as a recent event.
31 Jul 2025
Director Appointment

Progress on Jayashree Satagopan was appointed as a CFO was appointed as a CFO on 01 Jul 2025 & has been associated with this company since 10 months 19 days . was documented.
01 Jul 2025
Director Appointment

Vidhi Dilip Shanghvi was appointed as a Whole-time director was appointed as a Whole-time director on 22 May 2025 & has been associated with this company since 11 months 29 days . was recorded as a recent event.
22 May 2025
Balance Sheet

The activity Sun Pharmaceutical Industries Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.
31 Mar 2025
Director Appointment

Progress on Rolf Karl Heinz Hoffmann was appointed as a Director was appointed as a Director on 15 Jun 2023 & has been associated with this company since 2 years 11 months . was documented.
15 Jun 2023

Explore recent activity and updates - View Recent Activity